Page 17 - Flying Physician Magazine Issue 1-2018
P. 17

sired, and for the length of time desired.   The development
     and commercialization of the inflatable penile prosthesis,   Jackson, G., N. Boon, I. Eardley, M. Kirby, J. Dean, G. Hackett,
     which remains the gold standard treatment for end-stage ED,   P. Montorsi, F. Montorsi, C. Vlachopoulos, R. Kloner, I.
     is primarily owing to the efforts of FPA member F. Brantley   Sharlip and M. Miner (2010). “Erectile dysfunction and
     Scott (1930 – 1991) (Mobley 2015).  Dr. Scott was truly a re-  coronary artery disease prediction: evidence-based guidance
     naissance man as a physician, scientist, author, artist, rancher,   and consensus.” Int J Clin Pract 64(7): 848-857.
     jeweler, sculptor, musician, entrepreneur, and of course pilot
     and airplane builder. Despite his untimely death in his home-  Kandeel, F. R., V. K. Koussa and R. S. Swerdloff (2001). “Male
     built Questair Venture in July 1991 as he prepared for Osh-  sexual function and its disorders: physiology, pathophysiology,
     kosh, his legacy remains profound and the hundreds of thou-  clinical investigation, and treatment.” Endocr Rev 22(3): 342-
     sands of men and their partners who have benefitted from his   388.
     invention remain indebted for his creative innovations.
        Of course, we anticipate in the coming decades new dis-  McCabe, M. P., I. D. Sharlip, E. Atalla, R. Balon, A. D. Fisher,
     coveries for treatment of ED, including stem cell therapy;   E. Laumann, S. W. Lee, R. Lewis and R. T. Segraves (2016).
     however currently, such alternatives remain investigational.    “Definitions of Sexual Dysfunctions in Women and Men:
     Forthcoming  developments  in  molecular  profiling  and  ad-  A Consensus Statement From the Fourth International
     vanced imaging, along with therapies targeted to reverse the   Consultation on Sexual Medicine 2015.” J Sex Med 13(2): 135-
     endothelial dysfunction precipitating ED will usher in an ap-  143.
     proach considered genuine “personalized medicine” and lead
     to both increased quality of life and improvements in overall   McKinlay,  J.  B.  (2000).  “The  worldwide  prevalence  and
     health. Whatever promise the future holds, no action can ever   epidemiology of erectile dysfunction.”  Int J Impot Res  12
     be realized without one essential aspect of ED diagnosis and   suppl 4: S6-S11.
     treatment…communication.
                                                              Mobley,  D.  F.  (2015).  “Early  history  of  inflatable  penile
     references                                               prosthesis surgery: a view from someone who was there.”
     Burnett, A. L., A. Nehra, R. H. Breau, D. J. Culkin, M. M.   Asian J Androl 17(2): 225-229.
     Faraday, L. S. Hakim, J. Heidelbaugh, M. Khera, K. T. McVary,
     M. M. Miner, C. J. Nelson, H. Sadeghi-Nejad, A. D. Seftel and   Nehra, A., G. Jackson, M. Miner, K. L. Billups, A. L. Burnett, J.
     A. W. Shindel (2018). “Erectile Dysfunction: AUA Guideline.”   Buvat, C. C. Carson, G. R. Cunningham, P. Ganz, I. Goldstein,
     J Urol. May 7.                                           A. T. Guay, G. Hackett, R. A. Kloner, J. Kostis, P. Montorsi,
                                                              M. Ramsey, R. Rosen, R. Sadovsky, A. D. Seftel, R. Shabsigh,
     Feldman, H. A., I. Goldstein, D. G. Hatzichristou, R. J. Krane   C. Vlachopoulos and F. C. Wu (2012). “The Princeton III
     and J. B. McKinlay (1994). “Impotence and its medical and   Consensus recommendations for the management of erectile
     psychosocial correlates: results of the Massachusetts Male   dysfunction and cardiovascular disease.”  Mayo Clin Proc
     Aging Study.” J Urol 151(1): 54-61.                      87(8): 766-778.

     Hodges, L. D., M. Kirby, J. Solanki, J. O’Donnell and D. A.
     Brodie (2007). “The temporal relationship between erectile
     dysfunction and cardiovascular disease.”  Int J Clin Pract
     61(12): 2019-2025.



        ABOUT THE AUTHOR

        Dr. Melissa Kaufman is Associate Professor of Urologic Surgery at Vanderbilt Medical Center.   She completed fellowship training in
        both Male Reconstruction and Female Pelvic Medicine and Reconstructive Surgery. Her practice focuses on female and male voiding
        dysfunction and incontinence, cancer survivorship, pelvic organ prolapse, neurourology, urologic congenitalism, urologic prosthetics,
        as well as reconstructive surgery for urethral stricture, fistula and trauma. She currently serves as the global principal investigator for a
        pivotal Phase III clinical trial to pioneer the first application of autologous cell therapy for urologic indications.

        Dr. Kaufman was honored as the 2017 recipient of the Zimskind Award from the Society for Urodynamics, Female Pelvic Medicine and
        Urogenital Reconstruction for outstanding contributions within 10 years of completion of training. She is an Assistant Editor for the
        Journal of Urology and a past-president of the Society of Women in Urology. Dr. Kaufman is exceptionally fortunate to have received
        the Tabari Award from the Flying Physicians Association, for now, the third time. She can be tracked down most weekends fly fishing,
        motorcycling on the Natchez Trace Parkway or at various regional airfields with her 1984 Beechcraft Bonanza A36, N6724T.



                                                                               The Flying Physician vol. 61 - Issue 1 2018      17
   12   13   14   15   16   17   18   19   20   21   22